THW (abrdn World Healthcare Fund)
Insider Trading Activity
Every open-market purchase and sale reported by THW officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-20 | Chris LaVictoire Mahai | Director | Buy | — | — |
| 2024-08-16 | Bill Maher | Director | Buy | — | — |
| 2024-07-18 | Rose DiMartino | Director | Buy | — | — |
| 2024-04-12 | Kathleen Goetz | Director | Buy | — | — |
| 2024-01-04 | Todd Reit | Director | Buy | — | — |
| 2022-03-24 | Kathleen Goetz | Director | Buy | — | — |
| 2022-01-27 | Kathleen Goetz | Director | Buy | — | — |
| 2021-04-08 | Thomas M Kent | Director | X | — | — |
| 2021-04-08 | Jeffrey Allen Bailey | Director | X | — | — |
| 2021-04-08 | WILLIAM S REARDON | Director | X | — | — |
| 2021-04-08 | LUCINDA H STEBBINS | Director | X | — | — |
| 2021-04-08 | DANIEL R OMSTEAD | President | X | — | — |
| 2021-03-01 | WILLIAM S REARDON | Director | Buy | — | — |
| 2021-02-23 | LUCINDA H STEBBINS | Director | Buy | — | — |
| 2020-09-23 | Jeffrey Allen Bailey | Director | Buy | — | — |
| 2020-03-17 | DANIEL R OMSTEAD | President | Buy | — | — |
| 2018-12-26 | DANIEL R OMSTEAD | President | Buy | — | — |
| 2018-01-29 | Thomas M Kent | Director | Buy | — | — |
| 2016-01-07 | Timothy L Gasperoni | — | Buy | — | — |
| 2015-08-18 | MICHAEL W BONNEY | Director | Buy | — | — |
| 2015-06-26 | DANIEL R OMSTEAD | President | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | President | 30,768 | — |
| — | Director | 10,917 | — |
| — | Director | 2,400 | — |
| — | Director | 1,946 | — |
| — | — | 1,592 | — |
| — | Director | 1,017 | — |
| — | Director | 1,000 | — |
| — | Director | 1,000 | — |
| — | Director | 1,000 | — |
| — | Director | 1,000 | — |
| — | Director | 980 | — |
| — | Director | 796 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the THW quote page; the site-wide leaderboard is on the insider transactions hub.